Project Grant R01DK145059
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Harvard Medical School a Project Grant of $830,414 on August 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative, which extends through June 30, 2030, aims to identify and characterize microbiome-derived sulfated metabolites and elucidate their immunological effects. The project employs bioinformatic...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard College a $421,250 Project Grant effective September 1, 2025, through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research to decipher and predict ecologically sensitive gut microbiome contributions to human metabolic health. The research employs experiment-based, causally informative methodologies across three...
- Federal Project Grant Award Summary Boston University Medical Campus received a $703,748 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through February 28, 2030. This award funds basic biomedical research aimed at elucidating the role of bacterial polyphosphates in exacerbating intestinal inflammation and inflammatory bowel...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $129,619 to the University of Colorado-Denver on September 1, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This Project Grant funds investigator-initiated biomedical research examining the interactions between the gut microbiome, intestinal development, and metabolic health outcomes following fetal growth restriction...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University $165,104 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on February 2, 2026, with a completion date of December 31, 2028. This Project Grant supports investigator-initiated biomedical research aimed at elucidating disease mechanisms and developing improved prevention and treatment strategies for...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded University of California, Los Angeles a $778,662 Project Grant effective April 6, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Genetic and Gut Microbial Regulation of Indole-3-Propionate in Metabolic Disease," will be conducted through the university's Office of Research...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Boston Children's Hospital a $168,900 project grant effective July 15, 2025, through May 31, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates the mechanistic pathways by which Blautia species—commensal bacteria—activate enteroendocrine cells to produce satiety hormones and support gastrointestinal...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pennsylvania a $798,039 Project Grant effective March 1, 2026, through January 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative will deliver computational modeling and experimental research aimed at understanding self-organization mechanisms in the intestinal epithelium, specifically...
- Federal Project Grant Award Summary Yale University received an $802,843 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 13, 2025, with an ultimate completion date of June 30, 2030. The grant supports biomedical research investigating the pathogenic mechanisms linking obesity and cardiometabolic complications in pediatric...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $296,676 Project Grant to the University of Pennsylvania on June 19, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This biomedical research project, titled "Dissecting the Gut-Hypothalamus Axis for Fructose Sensing" and scheduled for completion by December 31, 2027, investigates the neural mechanisms through which...
Harvard College's Office for Sponsored Programs received an $832,101 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 1, 2026, with completion targeted for March 31, 2030. The research project, titled "Deciphering Polyphenol Metabolism by the Human Gut Microbiome," will develop innovative experimental methodologies and workflows to understand how gut bacteria metabolize dietary polyphenols—compounds abundant in plant-derived foods and beverages—and how this microbial metabolism affects human health outcomes and disease risk. The deliverables will include identification and characterization of gut microbial enzymes responsible for polyphenol metabolism across multiple compound classes; elucidation of bioactivities and mechanisms of action for prominent polyphenol metabolites; and definition of in vivo consequences of bacterial polyphenol metabolism on colitis and gut microbiome composition. Building on established preliminary frameworks including genetic tools, enzyme discovery methods, and high-throughput bioactivity screening approaches, the research will generate molecular-level understanding of gut microbial-diet interactions to advance knowledge relevant to inflammatory bowel disease, cardiovascular disease, cancer, and diabetes prevention and management.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $832.1k | 5/19/26 |